Drug Trial Radar · NCT00282594
The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit
Last checked: Nov 20, 2026Latest source record: Jan 27, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
317
Actual
Start
Jul 2003
Primary completion
Not stated
Study completion Oct 2005
Sponsor
- Lead sponsor
- GenesysAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Novo Nordisk A/S
- First posted
- Jan 27, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We sought to determine if there is a benefit to using an insulin drip to control hyperglycemia in the surgical critical care unit for patients who undergo general and vascular surgery.
Conditions
- Sepsis
- Respiratory Failure
- Renal Failure
- Surgical Site Infection
Interventions
Novolin R (human recombinant Insulin)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Genesys Regional Medical Center
Grand Blanc, Michigan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.